Bio-Techne (TECH) News Today → 41 banks launch ‘crypto dollar’ (From Stansberry Research) (Ad) Free TECH Stock Alerts $83.80 +0.97 (+1.17%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 4:58 PM | marketbeat.comBrown Advisory Inc. Purchases 741,860 Shares of Bio-Techne Co. (NASDAQ:TECH)Brown Advisory Inc. raised its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1,094.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 809,635 shares of the biotechnology company's stock afterMay 18 at 9:28 PM | nz.finance.yahoo.comBio-Techne Corp (TE1.SG)May 18 at 5:11 PM | marketbeat.comJackson Square Partners LLC Has $115.52 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH)Jackson Square Partners LLC boosted its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 18.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,497,086 shares of the biotechnology company's stockMay 17 at 8:39 AM | marketbeat.comMassachusetts Financial Services Co. MA Boosts Stock Position in Bio-Techne Co. (NASDAQ:TECH)Massachusetts Financial Services Co. MA grew its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1,389.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 784,543 shares of the biotechnologyMay 16 at 5:13 AM | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Shares Purchased by Victory Capital Management Inc.Victory Capital Management Inc. grew its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 56.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,936 shares of the bMay 14, 2024 | finance.yahoo.comBio-Techne Corporation (TECH) Declined on Weak Q4 ResultsMay 14, 2024 | americanbankingnews.comBio-Techne Co. (NASDAQ:TECH) Receives Average Recommendation of "Moderate Buy" from AnalystsMay 13, 2024 | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Stock Holdings Decreased by Summit Creek Advisors LLCSummit Creek Advisors LLC reduced its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 7.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 263,902 shares of the biotechnology company's stock after selling 20,779 shares during the period. BMay 12, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Grows Position in Bio-Techne Co. (NASDAQ:TECH)Charles Schwab Investment Management Inc. lifted its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 2.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,439,919 shares ofMay 9, 2024 | finance.yahoo.comBio-Techne Third Quarter 2024 Earnings: Beats ExpectationsMay 8, 2024 | prnewswire.comBIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024May 8, 2024 | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Shares Sold by Swiss National BankSwiss National Bank cut its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 2.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 494,900 shares of the biotechnology company's stock after sellinMay 7, 2024 | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Shares Purchased by Spire Wealth ManagementSpire Wealth Management raised its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 38,075.5% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 59,172 shares of the biotechnology company's stock after purchasing an additional 59,May 7, 2024 | prnewswire.comBIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)May 6, 2024 | marketbeat.comNatixis Advisors L.P. Has $21.93 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)Natixis Advisors L.P. boosted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 28.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 284,192 shares of the biotechnology companMay 4, 2024 | finance.yahoo.comBio-Techne Corporation Just Recorded A 7.6% EPS Beat: Here's What Analysts Are Forecasting NextMay 4, 2024 | marketbeat.comRussell Investments Group Ltd. Acquires 83,569 Shares of Bio-Techne Co. (NASDAQ:TECH)Russell Investments Group Ltd. lifted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 65.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 212,227 shares of the bMay 3, 2024 | marketbeat.comVan ECK Associates Corp Sells 22,664 Shares of Bio-Techne Co. (NASDAQ:TECH)Van ECK Associates Corp lessened its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 13.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 142,901 shares of the biotechnoMay 2, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Cross Country Healthcare (CCRN) and Bio-Techne (TECH)May 2, 2024 | marketbeat.comBio-Techne's (TECH) "Buy" Rating Reiterated at BenchmarkBenchmark reiterated a "buy" rating and issued a $95.00 price objective on shares of Bio-Techne in a research report on Thursday.May 2, 2024 | marketbeat.comBio-Techne (NASDAQ:TECH) Posts Earnings Results, Beats Estimates By $0.03 EPSBio-Techne (NASDAQ:TECH - Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported $0.48 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.03. The business had revenue of $303.43 million for the quarter, compared to analyst estimates of $292.36 million. Bio-Techne had a return on equity of 14.21% and a net margin of 19.58%. The business's revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.47 earnings per share.May 2, 2024 | marketbeat.comBio-Techne Co. Plans Quarterly Dividend of $0.08 (NASDAQ:TECH)Bio-Techne Co. (NASDAQ:TECH) announced a quarterly dividend on Wednesday, May 1st. Shareholders of record on Monday, May 13th will be given a dividend of 0.08 per share by the biotechnology company on Friday, May 24th. This represents a $0.32 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date of this dividend is Friday, May 10th.May 2, 2024 | marketbeat.comBio-Techne (NASDAQ:TECH) PT Raised to $81.00Robert W. Baird boosted their price target on Bio-Techne from $73.00 to $81.00 and gave the company an "outperform" rating in a research note on Thursday.May 2, 2024 | finance.yahoo.comBio-Techne Corp (TECH) (Q3 2024) Earnings Call Transcript Highlights: Navigating Market ...May 2, 2024 | gurufocus.comQ3 2024 Bio-Techne Corp Earnings Call TranscriptMay 1, 2024 | finance.yahoo.comBio-Techne Corporation (NASDAQ:TECH) Shares Could Be 25% Above Their Intrinsic Value EstimateMay 1, 2024 | finance.yahoo.comBio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Here’s Why.May 1, 2024 | msn.comBroader Market Mostly Lower Ahead of an Expected Hawkish FOMCMay 1, 2024 | marketwatch.comBio-Techne Shares Rise 20% After 3Q EPS, Sales BeatsMay 1, 2024 | finance.yahoo.comBio-Techne Corp (TECH) Q3 Fiscal 2024 Earnings: Mixed Results Amid Market ChallengesMay 1, 2024 | marketbeat.comBio-Techne (NASDAQ:TECH) Shares Gap Up to $63.21Bio-Techne (NASDAQ:TECH) Shares Gap Up to $63.21May 1, 2024 | reuters.comBio-Techne beats third-quarter estimates on improving demand for biotech productsMay 1, 2024 | markets.businessinsider.comBio-Techne Corp. Q3 Profit Decreases, but beats estimatesMay 1, 2024 | prnewswire.comBIO-TECHNE DECLARES DIVIDENDMay 1, 2024 | prnewswire.comBIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTSApril 30, 2024 | markets.businessinsider.comBio-Techne earnings preview: what Wall Street is expectingApril 30, 2024 | prnewswire.comBIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORSApril 29, 2024 | finanznachrichten.deBio-Techne Corporation: Bio-Techne Announces New Distribution Agreement With Thermo Fisher ScientificApril 29, 2024 | markets.businessinsider.comBio-Techne In Distribution Agreement With Thermo Fisher ScientificApril 29, 2024 | prnewswire.comBIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFICApril 28, 2024 | marketbeat.comabrdn plc Raises Stock Position in Bio-Techne Co. (NASDAQ:TECH)abrdn plc increased its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 70.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 65,313 shares of the biotechnology company's stock afteApril 27, 2024 | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Shares Sold by Ownership Capital B.V.Ownership Capital B.V. lessened its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 21.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,395,246 shares of the biotechnology company's stock after selling 391,027 sApril 26, 2024 | prnewswire.comBIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAYApril 25, 2024 | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Position Raised by Sandhill Capital Partners LLCSandhill Capital Partners LLC increased its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 12.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 690,699 shares of the biotechnology company'sApril 24, 2024 | finance.yahoo.comCourt Finds Advanced Cell Diagnostics Patents Invalid in Lawsuit with Molecular InstrumentsApril 23, 2024 | marketbeat.comInternational Assets Investment Management LLC Buys Shares of 12,191 Bio-Techne Co. (NASDAQ:TECH)International Assets Investment Management LLC purchased a new stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 12,191 shares of the biotechnology compApril 22, 2024 | marketbeat.comHandelsbanken Fonder AB Purchases 370,000 Shares of Bio-Techne Co. (NASDAQ:TECH)Handelsbanken Fonder AB lifted its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1,116.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 403,148 shares of the biotechnology coApril 21, 2024 | marketbeat.comKornitzer Capital Management Inc. KS Boosts Holdings in Bio-Techne Co. (NASDAQ:TECH)Kornitzer Capital Management Inc. KS raised its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 27.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 245,375 shares of the biotechnology coApril 18, 2024 | markets.businessinsider.comNavigating 4 Analyst Ratings For Bio-TechneApril 18, 2024 | marketbeat.comBio-Techne (NASDAQ:TECH) Price Target Cut to $82.00 by Analysts at Deutsche Bank AktiengesellschaftDeutsche Bank Aktiengesellschaft decreased their price objective on shares of Bio-Techne from $85.00 to $82.00 and set a "buy" rating for the company in a research report on Thursday. Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. TECH Media Mentions By Week TECH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TECH News Sentiment▼1.340.42▲Average Medical News Sentiment TECH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TECH Articles This Week▼86▲TECH Articles Average Week Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NBIX News Today QGEN News Today RGEN News Today PCVX News Today EXEL News Today RVMD News Today IBRX News Today HALO News Today ARGX News Today CRSP News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TECH) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media41 banks launch ‘crypto dollar’Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Techne Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
